MedPhab’s Post

In order to successfully navigate the future of #healthscience, we need to embrace #AI and the role #semiconductors will play in propelling that technology forward. Semiconductor technology can lower the cost to do testing so we can be more competitive in the pharmaceutical market. Microelectronics can make a positive impact with chronic conditions. If the right infrastructure is in place, a virtuous flywheel can be created to predict events and treat health outcomes. Thank you Dr. Ahmad Bahai, for moderating this panel discussion and thank you Paul Gerrish, Dr. Dina Katabi, Dr. Greg Kovacs, and Dr. Max Shulaker, Senior Director of Biomedical Engineering at Analog Devices for sharing your perspectives at the #NSTCSymposium

👩🔬 EN | We're proud to highlight a major breakthrough in medical nanotechnology, inspired by the European Commission's SAFE-N-MEDTECH project. This initiative is transforming how nano-enabled medical devices transition from innovative ideas to real-world applications.   💡 The SAFE-N-Medtech project stands out for its Open Innovation Test Bed, a unique platform that simplifies the process of bringing nanotechnology-enhanced medical devices to the market. This involves comprehensive support in navigating regulatory landscapes and ensuring product safety and efficacy.   🔬 The project offers vital services for assessing nanomaterials, including regulatory guidance and clinical validation.   💉 It's a collaborative effort, bringing together 28 partners for a holistic approach to nanotech in medicine.   ✈️ Having already supported the commercialization of eight products, it demonstrates the power of this initiative.   👉🏼 Link to source in the first comment👇🏼   #NadetechInnovation #NanotechHealth #MedTech #HealthcareFuture #InnovationLeadership #ImprovingPeoplesLive

𝗪𝗵𝗮𝘁 𝗱𝗼𝗲𝘀 𝘁𝗵𝗶𝘀 𝗺𝗲𝗮𝗻 𝗳𝗼𝗿 𝘆𝗼𝘂𝗿 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵? With enhanced resolution and reduced photobleaching, you can capture every nuance of cellular activity without compromising quality. Whether in drug discovery or CLD, our cutting-edge optical performance ensures that no detail goes unnoticed. 🔬 Experience imaging on a whole new level! The #CELLAVISTA   provides ultrafast, automated imaging with a true 0.8 μm resolution at 10x - perfect for high-precision cell research and detecting even the smallest cell fragments. Our advanced optical systems shorten exposure times and minimize photobleaching, enabling you to work faster and more reliably. 🔗 Discover the advantages: https://lnkd.in/eQw_zt-c #CellResearch #Imaging #Biotech #Innovation #Fluorescence #HighThroughput #Optics #Automation

We're thrilled to announce a groundbreaking feature in our Nanopartizer system that promises to revolutionize nanoparticle analysis: the ability to significantly decrease multiple scattering factors by focusing on a smaller region inside the sample. By concentrating on a smaller area within the sample, Nanopartizer reduces the volume of the sample required and eliminates the need for sensitive and expensive detectors. This results in a substantial increase in signal-to-noise ratio (#SNR), enhancing the accuracy and reliability of nanoparticle analysis. This #innovation represents a significant leap forward in nanoparticle characterization, offering researchers and industry professionals unparalleled #precision and #efficiency in their analyses. With Nanopartizer, users can confidently explore the intricate world of nanoparticles, unlocking new insights and driving advancements in various fields. Stay tuned for more updates and announcements from Nanopartizer as we continue to push the boundaries of nanoparticle analysis and pave the way for groundbreaking discoveries. #technology #innovative #tech #nanotech #nano

Healthcare and tech industries at forefront of nanotechnology innovation with rapid commercialisation - https://bit.ly/4emdfFn | #commercialisation_of_nanotech #diagnostics #drug_delivery #Healthcare #Medical_imaging #nanotechnology

Highlighting recent #EICTransition winners! The EIC Transition funding scheme is designed to facilitate the transition of high-potential ideas from the research stage to the market. This funding mechanism primarily targets projects that have already demonstrated their scientific excellence in previously funded research projects. The scheme aims to bridge the gap between developing novel technologies and their commercial application, offering financial support to cover activities such as applied research, product development, and validation in real-world settings. At the September 2023 cut-off, the EIC received 257 proposals, of which 27 were recently awarded funding. We are thrilled to announce that 3 projects supported by Zaz Ventures are among the winners: The GAIA project, coordinated by Azalea Vision, will revolutionise eye care through smart contact lens technology based on graphene electronics and liquid crystal cells, providing adaptive, effective, non-invasive and accessible solutions for patients. The Welinq project, coordinated by Welinq, will develop solutions to interconnect quantum processors to drastically increase their computational power and make them quantum-accessible at a distance. The Coati-X project, coordinated by CMD-COAT SA, will work on developing bioactive coatings to prevent infection and thrombosis of catheters and other implantable medical devices. With investment in these projects, the European Commission is dedicating resources to advance the upcoming wave of #quantum, #communication, and #healthtech technologies. These innovations are crucial in securing European technological independence and promoting industrial revitalisation. Do you have a technology at TRL 3-4 that needs further development originating from a qualified research project? Are you planning a spin-out from a research lab? Grants of up to €2.5M are available to validate and demonstrate technology in application-relevant environments and develop market readiness. The next deadline will be on the 18th of September. Contact us today for more information! 

🔬- User story: Based on your previous experience, you're asked to collaborate on optimizing microfluidic channel designs for a biochip/flowcell application. 💡 Using advanced optimization techniques, you developed a method to enhance the performance of microfluidic devices by maximizing flow rate, minimizing pressure drop, and improving mixing efficiency. 🌊 🔍- Explanation: The approach involves defining an objective function that encapsulates key performance metrics of the microfluidic channel, including flow rate, pressure drop, and mixing efficiency. The design space was systematically explored by analyzing an objective function and identifying optimal solutions, such as the optimal minima. In the following plot, the optimization landscape is visualized using a contour plot, which provides insights into the relationship between design variables (such as channel width and height) and performance metrics. This visualization allows us to pinpoint design space regions that correspond to optimal performance, enabling us to make informed design decisions. Furthermore, the optimal solution is marked on the plot, indicating the specific channel width and height combination that maximizes performance according to the defined objective function. This information is invaluable for refining microfluidic channel designs and enhancing their functionality for various biomedical applications. Objective functions are a significant step forward in microfluidics, offering new possibilities for diagnostic assays, drug delivery systems, and lab-on-a-chip technologies, including sequencing flowcells, biochips, microarrays, and molecular diagnostic point-of-care devices. 🚀💊 #BiomedicalEngineering #Biotech #Microfluidics #Biochip #Flowcell #Optimization #ResearchBreakthroughs

Microfluidic chips: recent advances, critical strategies in design, applications and future perspectives

FPT Software on #Nanotechnology in #Healthcare Nanotechnology is making waves in the healthcare industry, offering groundbreaking solutions that are transforming patient care. This innovative technology is opening up new possibilities for precision treatment, early diagnosis, and advanced drug delivery systems. ✔️ Precision Treatment: Nanotechnology allows for targeted therapies that directly attack diseased cells without harming healthy ones. ✔️ Early Diagnosis: Nanoscale sensors and imaging agents enable the detection of diseases at their earliest stages. ✔️ Advanced Drug Delivery: Nanocarriers can deliver drugs directly to specific cells, improving efficacy and reducing side effects. Explore the fascinating world of nanotechnology and its profound impact on healthcare in this terrific article by FPT Software. 👉 Read the full article here https://buff.ly/3URuea3 #Nanotechnology #HealthTech #Innovation #PatientCare #Healthcare #FPTSoftware Tagging leaders for insights: @eViRaHealth @FPT-Software @fpt-software-americas @irmaraste

Having worked in the industry, I know how crucial standards like ISO - International Organization for Standardization and ASME (The American Society of Mechanical Engineers) are for safety and consistency. When I started working on Microfluidics for Biological Applications, I was surprised to find no standardization. The same principles are now being applied to the emerging field of organ-on-chip (OoC) technologies, and it’s a game-changer. Organ-on-chip devices, which mimic the functions of human organs using microchip technology, hold incredible potential for revolutionizing healthcare, drug discovery, and more. But to truly unlock this potential, we need standardized guidelines that ensure reproducibility, user-friendliness, and global interoperability. Recently, over 120 European experts, including scientists, researchers, and industry leaders, collaborated for two years to create the first-ever Roadmap on Organ-on-Chip devices. This roadmap, supported by NEN, marks a significant milestone toward ISO standardization, ensuring that OoC technologies can be widely adopted and trusted across industries. In my next post, I'll summarize the roadmap. I would like to thank Carlo Alberto Paggi, PhD for helping to spread the word. #OrganOnChip #Microfluidics #Standardization #Innovation #Regulation #Healthcare #Biotech